• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真菌感染:发病机制、抗真菌药物及替代治疗方法。

Fungal infections: Pathogenesis, antifungals and alternate treatment approaches.

作者信息

Reddy G Kiran Kumar, Padmavathi Alwar Ramanujam, Nancharaiah Y V

机构信息

Biofouling and Biofilm Processes Section, Water and Steam Chemistry Division, Chemistry Group, Bhabha Atomic Research Centre, Kalpakkam 603 102, Tamil Nadu, India.

Homi Bhabha National Institute, Anushakti Nagar, Mumbai 400 094, India.

出版信息

Curr Res Microb Sci. 2022 Apr 27;3:100137. doi: 10.1016/j.crmicr.2022.100137. eCollection 2022.

DOI:10.1016/j.crmicr.2022.100137
PMID:35909631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9325902/
Abstract

Increasing incidence of fungal infections of recent times requires immediate intervention. Fungal infections are seldom construed at initial stages that intensify the severity of infections and complicate the treatment procedures. Fungal pathogens employ various mechanisms to evade the host immune system and to progress the severity of infections. For the treatment of diverse superficial and systemic infections, antifungal drugs from the available repertoire are administered. However, well documented evidence of fungal resistance to most of the antifungal drugs hampers disease control and poses challenges in antifungal therapy. Several physiological adaptations and genetic mutations followed by their selection in presence of antifungal agents drive the resistance development in fungi. The availability of limited antifungal arsenal, emergence of resistance and biofilm-conferred resistance drives the need for development of novel drugs and alternate approaches for the better treatment outcome against mycoses. This graphical review explicitly shed light on various fungal infections and causative organisms, pathogenesis, different antifungal drugs and resistance mechanisms including host immune response and evasion strategies. Here, we have highlighted recent developments on novel antifungal agents and other alternate approaches for fighting against fungal infections.

摘要

近年来真菌感染发病率的上升需要立即采取干预措施。真菌感染在初始阶段很少被识别,这加剧了感染的严重程度并使治疗程序复杂化。真菌病原体采用各种机制来逃避宿主免疫系统并加重感染的严重程度。为了治疗各种浅表和全身感染,会使用现有药物库中的抗真菌药物。然而,有充分记录的证据表明真菌对大多数抗真菌药物具有耐药性,这阻碍了疾病控制并对抗真菌治疗提出了挑战。真菌在抗真菌剂存在的情况下发生的几种生理适应和基因突变及其选择推动了真菌耐药性的发展。抗真菌药物库有限、耐药性的出现以及生物膜赋予的耐药性促使人们需要开发新药和采用替代方法,以更好地治疗真菌病。这篇图文综述明确阐述了各种真菌感染及其致病生物、发病机制、不同的抗真菌药物和耐药机制,包括宿主免疫反应和逃避策略。在此,我们重点介绍了新型抗真菌药物和其他对抗真菌感染的替代方法的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/4830bbd7a0a0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/c797b7b98d22/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/5b1308f17baf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/fe386a3f7082/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/c1f5e29826c9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/1ea1133faea7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/4830bbd7a0a0/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/c797b7b98d22/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/5b1308f17baf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/fe386a3f7082/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/c1f5e29826c9/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/1ea1133faea7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6393/9325902/4830bbd7a0a0/gr5.jpg

相似文献

1
Fungal infections: Pathogenesis, antifungals and alternate treatment approaches.真菌感染:发病机制、抗真菌药物及替代治疗方法。
Curr Res Microb Sci. 2022 Apr 27;3:100137. doi: 10.1016/j.crmicr.2022.100137. eCollection 2022.
2
The Road Ahead: Advancing Antifungal Vaccines and Addressing Fungal Infections in the Post-COVID World.未来之路:推进抗真菌疫苗并应对后 COVID 世界中的真菌感染。
ACS Infect Dis. 2024 Oct 11;10(10):3475-3495. doi: 10.1021/acsinfecdis.4c00245. Epub 2024 Sep 10.
3
Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia.使用γ干扰素和集落刺激因子对白血病患者难治性真菌感染进行免疫调节
Cancer. 2005 Jul 1;104(1):199-204. doi: 10.1002/cncr.21142.
4
Progress and prospects for targeting Hsp90 to treat fungal infections.靶向热休克蛋白90治疗真菌感染的研究进展与前景
Parasitology. 2014 Aug;141(9):1127-37. doi: 10.1017/S0031182013002072. Epub 2014 Feb 20.
5
An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease.一种抗毒力方法,通过新型天然产物抑制剂阻止新型隐球菌穿过血脑屏障的真菌金属蛋白酶。
mBio. 2020 Jul 21;11(4):e01249-20. doi: 10.1128/mBio.01249-20.
6
Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections.提高患有真菌感染的造血移植受者免疫功能的策略。
Bone Marrow Transplant. 2006 Sep;38(5):327-37. doi: 10.1038/sj.bmt.1705439.
7
Cytokines in immunodeficient patients with invasive fungal infections: an emerging therapy.免疫缺陷患者侵袭性真菌感染中的细胞因子:一种新兴疗法。
Int J Infect Dis. 2002 Sep;6(3):154-63. doi: 10.1016/s1201-9712(02)90104-9.
8
Decoding cell death signals in liver inflammation.解析肝炎症中的细胞死亡信号。
J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6.
9
Structure-guided approaches to targeting stress responses in human fungal pathogens.靶向人类真菌病原体应激反应的结构导向方法。
J Biol Chem. 2020 Oct 16;295(42):14458-14472. doi: 10.1074/jbc.REV120.013731. Epub 2020 Aug 12.
10
Antifungals discovery: an insight into new strategies to combat antifungal resistance.抗真菌药物的发现:对抗真菌耐药性新策略的洞察
Lett Appl Microbiol. 2018 Jan;66(1):2-13. doi: 10.1111/lam.12820. Epub 2017 Dec 11.

引用本文的文献

1
Extracellular Vesicles From Fungal Infection in Humans: A Key Player in Immunological Responses.人类真菌感染产生的细胞外囊泡:免疫反应中的关键参与者。
J Extracell Biol. 2025 Aug 27;4(8):e70065. doi: 10.1002/jex2.70065. eCollection 2025 Aug.
2
Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects.应对全球抗真菌挑战:医学与农业层面
ACS Bio Med Chem Au. 2025 Jul 2;5(4):531-552. doi: 10.1021/acsbiomedchemau.5c00103. eCollection 2025 Aug 20.
3
The prevalence of pediatric nosocomial fungal infections.儿童医院获得性真菌感染的患病率。

本文引用的文献

1
Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19.与新冠病毒相关的继发性细菌和真菌感染的替代治疗策略
Infect Dis Ther. 2022 Feb;11(1):53-78. doi: 10.1007/s40121-021-00559-8. Epub 2021 Nov 22.
2
Role of Antifungal Combinations in Difficult to Treat Infections.抗真菌联合用药在难治性感染中的作用
J Fungi (Basel). 2021 Sep 6;7(9):731. doi: 10.3390/jof7090731.
3
Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303).
Iran J Microbiol. 2025 Aug;17(4):644-652. doi: 10.18502/ijm.v17i4.19258.
4
Extended Antimicrobial Profile of Chromone-Butenafine Hybrids.色酮-布替萘芬杂合物的扩展抗菌谱
Molecules. 2025 Jul 15;30(14):2973. doi: 10.3390/molecules30142973.
5
Fungal Biofilm: An Overview of the Latest Nano-Strategies.真菌生物膜:最新纳米策略概述
Antibiotics (Basel). 2025 Jul 17;14(7):718. doi: 10.3390/antibiotics14070718.
6
Multifaceted Biological Properties of Verbascoside/Acteoside: Antimicrobial, Cytotoxic, Anti-Inflammatory, and Immunomodulatory Effects.毛蕊花糖苷/洋丁香酚苷的多方面生物学特性:抗菌、细胞毒性、抗炎和免疫调节作用
Antibiotics (Basel). 2025 Jul 11;14(7):697. doi: 10.3390/antibiotics14070697.
7
Novel Synthesis of the Antifungal Cyclic Lipopeptide Iturin A and Its Fluorinated Analog for Structure-Activity Relationship Studies.用于构效关系研究的抗真菌环脂肽伊枯草菌素A及其氟化类似物的新型合成
Chemistry. 2025 Aug 21;31(47):e01341. doi: 10.1002/chem.202501341. Epub 2025 Jul 25.
8
Effective treatment of systemic candidiasis by synergistic targeting of cell wall synthesis.通过协同靶向细胞壁合成有效治疗全身性念珠菌病。
Nat Commun. 2025 Jul 1;16(1):5532. doi: 10.1038/s41467-025-60684-7.
9
Prospective on Alkaloids-based sustainable methods to treat fungal pathogens: a comprehensive review.基于生物碱的真菌病原体可持续治疗方法的前瞻性研究:全面综述
Arch Microbiol. 2025 Jun 21;207(8):183. doi: 10.1007/s00203-025-04381-5.
10
Fungistatic activity and mechanism of , fractions and caulerpin metabolite against pathogenic fungi.、馏分及刺松藻素代谢产物对致病真菌的抑菌活性及其作用机制
Narra J. 2025 Apr;5(1):e1714. doi: 10.52225/narra.v5i1.1714. Epub 2025 Jan 1.
伊布列康唑治疗外阴阴道念珠菌病的 3 期随机、安慰剂对照优效性试验(VANISH 303)。
Clin Infect Dis. 2022 Jun 10;74(11):1979-1985. doi: 10.1093/cid/ciab750.
4
Host Response to Infection: Fungal Immunity.宿主对感染的反应:真菌感染免疫。
Front Cell Infect Microbiol. 2020 Nov 11;10:581101. doi: 10.3389/fcimb.2020.581101. eCollection 2020.
5
Antifungal Drug Repurposing.抗真菌药物的重新利用。
Antibiotics (Basel). 2020 Nov 15;9(11):812. doi: 10.3390/antibiotics9110812.
6
Alkylimidazolium Ionic Liquids as Antifungal Alternatives: Antibiofilm Activity Against and Underlying Mechanism of Action.烷基咪唑鎓离子液体作为抗真菌替代品:对生物膜的抗菌活性及作用机制
Front Microbiol. 2020 Apr 21;11:730. doi: 10.3389/fmicb.2020.00730. eCollection 2020.
7
Drug resistance and tolerance in fungi.真菌的耐药性和耐受性。
Nat Rev Microbiol. 2020 Jun;18(6):319-331. doi: 10.1038/s41579-019-0322-2. Epub 2020 Feb 11.
8
Impediment to growth and yeast-to-hyphae transition in by copper oxide nanoparticles.氧化铜纳米颗粒对 的生长和酵母-菌丝过渡的阻碍。
Biofouling. 2020 Jan;36(1):56-72. doi: 10.1080/08927014.2020.1715371. Epub 2020 Jan 30.
9
Pathogenic Fungal Infection in the Lung.肺部病原真菌感染。
Front Immunol. 2019 Jul 3;10:1524. doi: 10.3389/fimmu.2019.01524. eCollection 2019.
10
Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi.临床上相关真菌的适应性和抗真菌耐药机制的促进因素。
Fungal Genet Biol. 2019 Nov;132:103254. doi: 10.1016/j.fgb.2019.103254. Epub 2019 Jul 19.